AbGenomics International's Series C Round

AbGenomics International raised a round of funding on August 27, 2014.

AbGenomics International is a biopharmaceutical company focused on the discovery and development of medicines to treat diseases with unmet medical need and significant market potential. The company ha…

Articles about AbGenomics International's Series C Round: